Adaptive Hybrid Surgery Analysis

About Adaptive Hybrid Surgery Analysis

General Information

Adaptive Hybrid Surgery Analysis enables you to compare the effects of potential radiotherapy treatment plans for patients with benign tumors. This helps you decide:

  • Whether radiotherapy is appropriate for the tumor, such as, benign skull base tumors, or,

  • Whether you should perform surgery in order to make radiotherapy possible.

Adaptive Hybrid Surgery Analysis can be performed pre-operatively or intraoperatively.

Safety Notes

When using Adaptive Hybrid Surgery Analysis:

  • Do not depend entirely on the software for doing surgery.

  • Surgical risks always have a higher priority than risks indicated by this software.

  • This software does not show where to resect tumor volume. It is solely the surgeon’s decision to define the extent of a subtotal tumor resection based on surgical expertise.

  • As Adaptive Hybrid Surgery Analysis does not create the final treatment plan, and the final plan may be different, problematic areas visible in the GUI, e.g. dose hot spots, do not directly threaten the patient.

  • The software only shows risks emerging from radiation treatment simulation. Surgical risks are not taken into account in the Radiation Plan Analysis Table and must be included in the decision process by the surgeon.

  • Carefully check if the same tumor object is selected in all applications used in a workflow (e.g., Adaptive Hybrid Surgery Analysis, Cranial Navigation and Intraoperative Structure Update.

Warning

Patient Datasets

Data sets used to simulate a dose plan:

  • Must contain the whole head.

  • Must contain the risk structures/objects.

  • Must be modality MR.

  • Must either be clipped at the top or any other side.

  • Must not contain any angulations.

  • Must not contain a localizer.

  • Must consist of pure axial images.

  • Must contain patient images strictly in the supine position.

Article No. 60912-83EN

Fecha de publicación: 2015-09-27